Oudsema Rebecca, Hwang Esther, Steinberger Sharon, Yip Rowena, Margolies Laurie R
Mount Sinai Hospital, Department of Radiology, New York, NY.
J Breast Imaging. 2020 Jun 3;2(3):217-224. doi: 10.1093/jbi/wbaa003.
To understand physicians' comprehension of breast cancer screening guidelines and the existing literature on breast cancer screening, and whether this contributes to how patient screening is implemented in clinical practice.
A survey of 18 questions was distributed across the United States via e-mail and social media resources to physicians and medical students of all disciplines and levels of training. Responses from 728 physicians and medical students were reviewed. Respondents were from over 200 different institutions and over 60 different medical specialties.
Our survey demonstrates that more than half of the participants felt uncomfortable in their knowledge of breast cancer screening recommendations (399/728, 54.8%) and existing literature on breast cancer screening (555/728, 76.2%). When stratified based on level of training, those at the attending level reported a greater level of comfort in their knowledge of breast cancer screening recommendations (168/238, 70.6%) and literature (95/238, 39.9%) compared with respondents at the trainee level. Attending physicians are also more likely to recommend screening for patients between the ages of 40-49 years old (209/238, 87.7%) compared to those at the trainee level. Responses on whether to screen based on age were most consistent for patients ages 50-74, with greater than 90% of the respondents endorsing screening mammogram for this age group in all levels of training. There were greater inconsistencies in the support to screen age groups 40-49 and 75+ .
The results showed a disparity in screening practices by clinicians in all levels of training, particularly for patients ages 40-49 and 75+ , and for the interval of screening. Later initiation with less frequent intervals between screens may reduce the impact of screening on mortality reduction.
了解医生对乳腺癌筛查指南及现有乳腺癌筛查文献的理解,以及这是否影响临床实践中患者筛查的实施方式。
通过电子邮件和社交媒体资源向美国各地所有学科和培训水平的医生及医学生发放了一份包含18个问题的调查问卷。对728名医生和医学生的回复进行了审查。受访者来自200多个不同机构和60多个不同医学专科。
我们的调查表明,超过一半的参与者对自己关于乳腺癌筛查建议(399/728,54.8%)和现有乳腺癌筛查文献(555/728,76.2%)的了解感到不自信。按培训水平分层时,与实习医生相比,主治医生对自己关于乳腺癌筛查建议(168/238,70.6%)和文献(95/238,39.9%)的了解更自信。与实习医生相比,主治医生也更有可能建议对40 - 49岁的患者进行筛查(209/238,87.7%)。对于是否根据年龄进行筛查的回答,在50 - 74岁患者中最为一致,所有培训水平中超过90%的受访者支持该年龄组进行乳腺钼靶筛查。在支持对40 - 49岁和75岁以上年龄组进行筛查方面存在更大的不一致性。
结果显示,所有培训水平的临床医生在筛查实践中存在差异,特别是对于40 - 49岁和75岁以上的患者以及筛查间隔。筛查开始时间较晚且筛查间隔时间较短可能会降低筛查对降低死亡率的影响。